Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Leestemaker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Methods|December 2, 2015
Hitting the targetYves Leestemaker, Huib Ovaa
Drug Discovery Today. Technologies|December 19, 2017
Tools to investigate the ubiquitin proteasome systemYves Leestemaker, Huib Ovaa
Frontiers in Molecular Biosciences|April 11, 2019
Highlighting the Proteasome: Using Fluorescence to Visualize Proteasome Activity and DistributionJin Gan, Yves Leestemaker, Aysegul Sapmaz, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2016
Profiling the Activity of Deubiquitinating Enzymes Using Chemically Synthesized Ubiquitin-Based ProbesYves Leestemaker, Annemieke de Jong, Huib Ovaa
Molecular Pharmaceutics|March 22, 2012
Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomibCelia R Berkers, Yves Leestemaker, Karianne G Schuurman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2017
Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen PresentationAmy L Palmer, Annemieke de Jong, Yves Leestemaker, et al.
Cell Chemical Biology|May 30, 2017
Proteasome Activation by Small MoleculesYves Leestemaker, Annemieke de Jong, Katharina F Witting, et al.
Cell Stem Cell|January 29, 2019
Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease NeuronsRik van der Kant, Vanessa F Langness, Cheryl M Herrera, et al.
The Journal of Clinical Investigation|August 29, 2017
Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specificationChristella E Widjaja, Jocelyn G Olvera, Patrick J Metz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Methods|December 2, 2015
Hitting the targetYves Leestemaker, Huib Ovaa
Drug Discovery Today. Technologies|December 19, 2017
Tools to investigate the ubiquitin proteasome systemYves Leestemaker, Huib Ovaa
Frontiers in Molecular Biosciences|April 11, 2019
Highlighting the Proteasome: Using Fluorescence to Visualize Proteasome Activity and DistributionJin Gan, Yves Leestemaker, Aysegul Sapmaz, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2016
Profiling the Activity of Deubiquitinating Enzymes Using Chemically Synthesized Ubiquitin-Based ProbesYves Leestemaker, Annemieke de Jong, Huib Ovaa
Molecular Pharmaceutics|March 22, 2012
Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomibCelia R Berkers, Yves Leestemaker, Karianne G Schuurman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2017
Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen PresentationAmy L Palmer, Annemieke de Jong, Yves Leestemaker, et al.
Cell Chemical Biology|May 30, 2017
Proteasome Activation by Small MoleculesYves Leestemaker, Annemieke de Jong, Katharina F Witting, et al.
Cell Stem Cell|January 29, 2019
Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease NeuronsRik van der Kant, Vanessa F Langness, Cheryl M Herrera, et al.
The Journal of Clinical Investigation|August 29, 2017
Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specificationChristella E Widjaja, Jocelyn G Olvera, Patrick J Metz, et al.
Pageof 1